Preliminary experiments reveal conolidine may well inhibit unique ion channels, lowering neuronal excitability and restricting discomfort signals. This system is particularly applicable in neuropathic pain, in which irregular signaling brings about persistent distress. Additionally, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to suffering perception.... https://fidelg690tjj4.nizarblog.com/profile